dalteparin has been researched along with Anterior Fascicular Block in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Recently, the use of safe-dose recombinant tissue-type plasminogen activator (rTPA) has been proposed for the treatment of moderate PE demonstrating to be safe and more effective than standard anticoagulation." | 2.50 | [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature]. ( Cannone, M; La Torre, PP; Mele, A; Mele, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mele, M | 1 |
| Mele, A | 1 |
| La Torre, PP | 1 |
| Cannone, M | 1 |
| Cohen, M | 1 |
| Gensini, GF | 1 |
| Maritz, F | 1 |
| Gurfinkel, EP | 1 |
| Huber, K | 1 |
| Timerman, A | 1 |
| Krzeminska-Pakula, M | 1 |
| Santopinto, J | 1 |
| Hecquet, C | 1 |
| Vittori, L | 1 |
| Yusuf, S | 1 |
| Mehta, SR | 1 |
| Xie, C | 1 |
| Ahmed, RJ | 1 |
| Xavier, D | 1 |
| Pais, P | 1 |
| Zhu, J | 1 |
| Liu, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility[NCT05160311] | 70 participants (Anticipated) | Interventional | 2021-08-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dalteparin and Anterior Fascicular Block
| Article | Year |
|---|---|
[Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Topics: Aged, 80 and over; Anemia, Hypochromic; Anticoagulants; Bundle-Branch Block; Diabetes Complications; | 2014 |
2 trials available for dalteparin and Anterior Fascicular Block
| Article | Year |
|---|---|
Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
Topics: Age Factors; Aged; Anticoagulants; Bundle-Branch Block; Double-Blind Method; Drug Therapy, Combinati | 2003 |
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
Topics: Aged; Angina Pectoris, Variant; Anticoagulants; Bundle-Branch Block; Double-Blind Method; Female; He | 2005 |